NO983906L - Anvendelse av karboniske anhydraseinhibitorer for behandling av makulµr °dem - Google Patents

Anvendelse av karboniske anhydraseinhibitorer for behandling av makulµr °dem

Info

Publication number: NO983906L
Authority: NO; Norway
Prior art keywords: carbonic anhydrase; macular degeneration; anhydrase inhibitors; treat macular; treat
Prior art date: 1996-02-26

Application number

NO983906A

Other languages

English (en)

Other versions

NO983906D0 (no

NO320043B1 (no

Inventor

William Eric Sponsel

Alon Harris

Original Assignee

Advanced Res & Tech Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-26

Filing date

1998-08-25

Publication date

1998-10-19

1996-03-18 Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en

1998-08-25 Application filed by Advanced Res & Tech Inst filed Critical Advanced Res & Tech Inst

1998-08-25 Publication of NO983906D0 publication Critical patent/NO983906D0/no

1998-10-19 Publication of NO983906L publication Critical patent/NO983906L/no

2005-10-17 Publication of NO320043B1 publication Critical patent/NO320043B1/no

Links

239000003489 carbonate dehydratase inhibitor Substances 0.000 title abstract 3
208000002780 macular degeneration Diseases 0.000 title abstract 2
229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 title 1
229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 2
206010025415 Macular oedema Diseases 0.000 abstract 1
206010064930 age-related macular degeneration Diseases 0.000 abstract 1
201000010230 macular retinal edema Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Eye Examination Apparatus (AREA)

NO19983906A 1996-02-26 1998-08-25 Anvendelse av karboniske anhydraseinhibitorer for fremstilling av et medikament for behandling eller forebyggelse av makulaer odem eller aldersrelatert makulaer degenerering NO320043B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1225096P	1996-02-26	1996-02-26
GBGB9605642.9A GB9605642D0 (en)	1996-03-18	1996-03-18	Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en)	1996-02-26	1997-02-25	Use of carbonic anhydrase inhibitors for treating macular edema

Publications (3)

Publication Number	Publication Date
NO983906D0 NO983906D0 (no)	1998-08-25
NO983906L true NO983906L (no)	1998-10-19
NO320043B1 NO320043B1 (no)	2005-10-17

Family

ID=26308946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19983906A NO320043B1 (no)	1996-02-26	1998-08-25	Anvendelse av karboniske anhydraseinhibitorer for fremstilling av et medikament for behandling eller forebyggelse av makulaer odem eller aldersrelatert makulaer degenerering

Country Status (26)

Country	Link
EP (1)	EP0954305B9 (no)
JP (1)	JP4392481B2 (no)
KR (1)	KR100471586B1 (no)
CN (1)	CN1225582A (no)
AT (1)	ATE239468T1 (no)
AU (1)	AU727565B2 (no)
BG (1)	BG64525B1 (no)
BR (1)	BR9707674A (no)
CA (1)	CA2247063C (no)
CZ (1)	CZ299509B6 (no)
DE (1)	DE69721824T2 (no)
DK (1)	DK0954305T3 (no)
EA (1)	EA001681B1 (no)
EE (1)	EE03804B1 (no)
ES (1)	ES2199348T4 (no)
HU (1)	HU227161B1 (no)
IL (1)	IL125912A0 (no)
IS (1)	IS2053B (no)
MX (1)	MXPA98006961A (no)
NO (1)	NO320043B1 (no)
NZ (1)	NZ331843A (no)
PT (1)	PT954305E (no)
SK (1)	SK284371B6 (no)
TR (1)	TR199801665T2 (no)
WO (1)	WO1997030704A2 (no)
YU (1)	YU49422B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9803226D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
CA2323749A1 (en) *	1998-03-06	1999-09-10	William E. Sponsel	Composition and method for treating macular disorders
US5948801A (en) *	1998-03-09	1999-09-07	Alcon Laboratories, Inc.	Treatment of retinal edema with brinzolamide
CN1311684A (zh) *	1998-07-10	2001-09-05	悉尼大学	黄斑变性中新生血管形成的预防治疗
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor
US20100063035A1 (en)	2006-12-15	2010-03-11	Nicox S.A.	Carbonic anhydrase inhibitors derivatives
AR084194A1 (es) *	2010-12-09	2013-04-24	Fovea Pharmaceuticals	Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
AU2017382176A1 (en)	2016-12-21	2019-05-30	Biotheryx, Inc.	Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4797413A (en) *	1986-05-14	1989-01-10	Merck & Co., Inc.	Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) *	1988-09-29	1992-03-18	American Cyanamid Co	Stable ophthalmic preparations containing methazolamide
US5153192A (en) *	1990-04-09	1992-10-06	Alcon Laboratories, Inc.	Thiophene sulfonamides useful as carbonic anhydrase inhibitors

1997
- 1997-02-25 WO PCT/US1997/002874 patent/WO1997030704A2/en not_active Ceased
- 1997-02-25 CZ CZ0269998A patent/CZ299509B6/cs not_active IP Right Cessation
- 1997-02-25 EA EA199800764A patent/EA001681B1/ru not_active IP Right Cessation
- 1997-02-25 EE EE9800263A patent/EE03804B1/xx not_active IP Right Cessation
- 1997-02-25 DK DK97907822T patent/DK0954305T3/da active
- 1997-02-25 IL IL12591297A patent/IL125912A0/xx not_active IP Right Cessation
- 1997-02-25 DE DE69721824T patent/DE69721824T2/de not_active Expired - Lifetime
- 1997-02-25 AT AT97907822T patent/ATE239468T1/de not_active IP Right Cessation
- 1997-02-25 PT PT97907822T patent/PT954305E/pt unknown
- 1997-02-25 JP JP53037997A patent/JP4392481B2/ja not_active Expired - Fee Related
- 1997-02-25 MX MXPA98006961A patent/MXPA98006961A/es active IP Right Grant
- 1997-02-25 SK SK1151-98A patent/SK284371B6/sk not_active IP Right Cessation
- 1997-02-25 BR BR9707674-0A patent/BR9707674A/pt not_active Application Discontinuation
- 1997-02-25 KR KR10-1998-0706643A patent/KR100471586B1/ko not_active Expired - Fee Related
- 1997-02-25 CN CN97192579A patent/CN1225582A/zh active Pending
- 1997-02-25 HU HU9902054A patent/HU227161B1/hu not_active IP Right Cessation
- 1997-02-25 NZ NZ331843A patent/NZ331843A/xx not_active IP Right Cessation
- 1997-02-25 CA CA002247063A patent/CA2247063C/en not_active Expired - Fee Related
- 1997-02-25 YU YU35398A patent/YU49422B/sh unknown
- 1997-02-25 ES ES97907822T patent/ES2199348T4/es not_active Expired - Lifetime
- 1997-02-25 EP EP97907822A patent/EP0954305B9/en not_active Expired - Lifetime
- 1997-02-25 TR TR1998/01665T patent/TR199801665T2/xx unknown
- 1997-02-25 AU AU19721/97A patent/AU727565B2/en not_active Ceased
1998
- 1998-08-20 IS IS4829A patent/IS2053B/is unknown
- 1998-08-25 NO NO19983906A patent/NO320043B1/no not_active IP Right Cessation
- 1998-09-25 BG BG102797A patent/BG64525B1/bg unknown

Also Published As

Publication number	Publication date
WO1997030704A3 (en)	1997-09-25
IS2053B (is)	2005-10-14
NZ331843A (en)	2000-09-29
YU35398A (sh)	2001-12-26
JP2000506833A (ja)	2000-06-06
IL125912A0 (en)	1999-04-11
MXPA98006961A (es)	2004-11-19
ES2199348T3 (es)	2004-02-16
EE9800263A (et)	1999-08-16
CZ269998A3 (cs)	2000-01-12
BG64525B1 (bg)	2005-06-30
CA2247063C (en)	2004-01-06
EE03804B1 (et)	2002-08-15
HU227161B1 (en)	2010-09-28
SK284371B6 (sk)	2005-02-04
CN1225582A (zh)	1999-08-11
AU727565B2 (en)	2000-12-14
DE69721824D1 (de)	2003-06-12
EA199800764A1 (ru)	1999-06-24
BG102797A (en)	1999-09-30
DE69721824T2 (de)	2004-03-11
JP4392481B2 (ja)	2010-01-06
ATE239468T1 (de)	2003-05-15
NO983906D0 (no)	1998-08-25
DK0954305T3 (da)	2003-08-25
IS4829A (is)	1998-08-20
BR9707674A (pt)	2000-01-04
AU1972197A (en)	1997-09-10
PT954305E (pt)	2003-09-30
YU49422B (sh)	2006-01-16
HUP9902054A3 (en)	2001-07-30
CA2247063A1 (en)	1997-08-28
EA001681B1 (ru)	2001-06-25
EP0954305A2 (en)	1999-11-10
EP0954305B9 (en)	2010-08-04
KR100471586B1 (ko)	2005-07-11
WO1997030704A2 (en)	1997-08-28
CZ299509B6 (cs)	2008-08-20
HUP9902054A1 (hu)	2000-03-28
SK115198A3 (en)	2000-01-18
EP0954305B1 (en)	2003-05-07
NO320043B1 (no)	2005-10-17
ES2199348T4 (es)	2010-10-19
KR19990087242A (ko)	1999-12-15
TR199801665T2 (xx)	1998-12-21

Legal Events

Date	Code	Title	Description
2011-09-26	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO983906D0 (no)	1998-08-25	Anvendelse av karboniske anhydraseinhibitorer for behandling av makulær ödem
DK0719154T3 (da)	2001-11-26	Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
AU2483000A (en)	2000-07-24	Treatment of asthma with mek inhibitors
AU7321598A (en)	1998-09-22	Use of cholinesterase inhibitors to treat disorders of attention
DE69424537D1 (de)	2000-06-21	Therapeutischer wirkstoff zur behandlung von melanomen
WO2000059487A3 (en)	2001-08-16	Flupirtine in the treatment of fibromyalgia and related conditions
CA2071629A1 (en)	1991-08-10	Use of insulin sensitizing agents to treat hypertension
DE69632632D1 (de)	2004-07-08	Behandlungsverfahren für darmadenome
WO2003004006A3 (en)	2003-05-30	Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
BG105875A (en)	2002-05-31	Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
ATE283044T1 (de)	2004-12-15	Compactin zur behandlung von entzündungen
UA66757C2 (en)	2004-06-15	Ophthalmologic composition of carbonic anhydrase inhibitors, method for treating or preventing macular edema or age-related macular degeneration
NZ313076A (en)	1999-11-29	Medicament containing duloxetine for treating hyperactivity and attention deficiency disorders
EE9700350A (et)	1998-10-15	COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
WO2001034546A3 (en)	2001-10-25	Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
WO1996036339A3 (en)	1997-02-13	Use of dihydrotestosterone compounds for treating male sexual dysfunction
NO984196D0 (no)	1998-09-11	Fremgangsmåte for behandling av stoffmisbruk
WO2002005796A3 (en)	2002-09-06	Use of a spla2 inhibitor for the treatment of sepsis
WO2004024085A3 (en)	2004-04-29	Use of pde iv inhibitors to treat angiogenesis
RU94042315A (ru)	1996-09-20	Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
NO982854L (no)	1998-06-19	Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes
NO984198L (no)	1998-11-02	FremgangsmÕte for behandling av aggresjon
AU4057789A (en)	1990-02-05	Method for using protease inhibitors to treat and/or prevent pancreatitis